VLTO.NYSEVeralto CORP

Form 4: Veralto Director Cindy Wallis-Lage Receives Equity Grant

Sentiment:

Insider Transaction Report


Veralto Corp Director Cindy L. Wallis-Lage was granted 818 restricted stock units and 2,265 stock options as part of her compensation, effective July 15, 2025.

Summary

  • Cindy L. Wallis-Lage, a Director of Veralto Corp (VLTO), acquired 818 shares of common stock through a grant of restricted stock units (RSUs) on July 15, 2025.
  • These RSUs were granted at a price of $0 and will vest on the earlier of the first anniversary of the grant date or immediately prior to the next annual meeting of Veralto's shareholders following the grant date.
  • The underlying shares from the RSUs are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board.
  • Following this transaction, Wallis-Lage beneficially owns 2,371 shares of common stock directly.
  • Additionally, Wallis-Lage was granted 2,265 Director Stock Options on July 15, 2025, with an exercise price of $100.95.
  • These options were granted at a price of $0 and are fully vested as of the grant date.
  • The options are exercisable from July 15, 2025, and expire on July 15, 2035.
  • After this transaction, Wallis-Lage beneficially owns 5,860 derivative securities (stock options) directly.

Sentiment

Score: 7

Explanation: The filing reports a standard equity compensation grant to a director, which is a positive for aligning interests and incentivizing performance. There are no negative or unexpected elements.

Positives

  • The grant of restricted stock units and stock options to Director Cindy L. Wallis-Lage aligns her interests with those of shareholders, incentivizing long-term company performance.
  • The immediate vesting of the 2,265 stock options provides immediate equity exposure and incentive for the director.
  • The acquisition of 818 common shares through RSUs increases the director's direct beneficial ownership, demonstrating commitment to the company.

Negatives

  • No specific negative aspects are detailed in this Form 4 filing, as it primarily reports a compensation-related equity grant.

Risks

  • No specific risks are mentioned in this Form 4 filing beyond the inherent risks associated with equity compensation (e.g., stock price fluctuations).

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the vesting schedule for the granted equity.

Management Comments

  • No direct quotes or paraphrased statements from company management are included in this Form 4 filing, which is a transactional report.

Industry Context

This Form 4 filing reports a routine equity compensation grant to a non-employee director, which is a standard practice across various industries to align director incentives with shareholder value. It does not provide broader industry trend analysis.

Comparison to Industry Standards

  • This filing details a standard equity compensation package for a non-employee director, which is a common practice in publicly traded companies across various sectors.
  • While specific comparable companies or projects are not mentioned, the structure of granting restricted stock units and stock options with vesting schedules and exercise prices is consistent with typical corporate governance and compensation practices for board members in the U.S. market, including companies like Danaher Corporation (Veralto's former parent company) or other large industrial technology firms.

Related Party Transactions

  • The grant of equity compensation (restricted stock units and stock options) to a director is considered a related party transaction, as it involves a transaction between the company and a member of its board of directors.

Stakeholder Impact

  • Shareholders: The equity grants align the director's financial interests with those of shareholders, potentially leading to better long-term decision-making and increased shareholder value.
  • Employees: No direct impact on general employees is indicated by this filing.
  • Customers: No direct impact on customers is indicated by this filing.
  • Suppliers: No direct impact on suppliers is indicated by this filing.
  • Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

  • The restricted stock units will vest on the earlier of the first anniversary of the grant date (July 15, 2026) or immediately prior to the next annual meeting of Veralto's shareholders following the grant date.
  • The underlying shares from the restricted stock units will be issued upon the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board.
  • The granted stock options are immediately vested and exercisable, and will expire on July 15, 2035.

Key Dates

DateDescription
07/15/2025Date of earliest transaction for the acquisition of common stock and director stock options.
07/15/2025Date when restricted stock units were granted and began vesting.
07/15/2025Date when director stock options were granted and became fully vested and exercisable.
07/15/2035Expiration date for the Director Stock Options.
07/17/2025Signature date of the reporting person's attorney-in-fact for the Form 4 filing.

Recommendation

hold

Keywords

Veralto Corp, VLTO, SEC Form 4, insider transaction, stock grant, restricted stock units, RSUs, stock options, director compensation, equity compensation, beneficial ownership, Cindy L. Wallis-Lage

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.